e-learning
resources
Amsterdam 2011
Monday, 26.09.2011
Assessment of severity and predictors of outcomes in community-acquired pneumonia
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Role of pneumococcus urinary antigen testing in the clinical presentation and outcome of pneumococcal bacteraemic community acquired pneumonia
L. A. Ruiz, M. Alfonso, A. Gomez, S. Pedrero, N. Marina, M. Inchausti, I. Seijas, C. Jaca, R. Zalacain (Barakaldo, Spain)
Source:
Annual Congress 2011 - Assessment of severity and predictors of outcomes in community-acquired pneumonia
Session:
Assessment of severity and predictors of outcomes in community-acquired pneumonia
Session type:
Thematic Poster Session
Number:
2484
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. A. Ruiz, M. Alfonso, A. Gomez, S. Pedrero, N. Marina, M. Inchausti, I. Seijas, C. Jaca, R. Zalacain (Barakaldo, Spain). Role of pneumococcus urinary antigen testing in the clinical presentation and outcome of pneumococcal bacteraemic community acquired pneumonia. Eur Respir J 2011; 38: Suppl. 55, 2484
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Usefulness of urinary pneumococcal antigen testing in patients with community acquired pneumonia
Source: Annual Congress 2009 - Aetiology and diagnosis of lower respiratory tract infections
Year: 2009
Assessment of urinary pneumococcal antigen for etiological diagnosis of community-acquired pneumonia
Source: Annual Congress 2003 - New aspects of community acquired pneumonia
Year: 2003
Clinical features of patients with pneumococcal urinary antigen positivity, in a cohort of hospitalised community acquired pneumonia
Source: Annual Congress 2012 - Prognostic indices in respiratory infections
Year: 2012
Impact of determination of urine pneumococcal antigen in the diagnosis of community acquired pneumonia
Source: Annual Congress 2008 - Diagnostic tests in lower respiratory tract infections
Year: 2008
Sputum and streptococcus pneumoniae urinary antigen test for diagnosis of pneumococcal community acquired pneumonia
Source: Annual Congress 2008 - Diagnostic tests in lower respiratory tract infections
Year: 2008
Rapid urinary antigen test for diagnosis of pneumococcal community-acquired pneumonia in adults
Source: Eur Respir J 2003; 21: 209-214
Year: 2003
Predisposing factors for bacteremia in patients with community-acquired pneumonia and positive pneumococcal urinary antigen
Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment
Year: 2016
Investigation of factors associated with result of pneumococcal urinary antigen in the microbiological investigation of pneumococcal lower respiratory infections
Source: International Congress 2017 – CAP: severity scores, risk groups and biomarkers
Year: 2017
The relationship between the result of urinary antigen detection kit for
Streptococcus pneumoniae
and clinical effect of treatment in patients with pneumococcal pneumonia
Source: Eur Respir J 2004; 24: Suppl. 48, 412s
Year: 2004
Pneumococcal urinary antigen test use in diagnosis and treatment of pneumonia in seven Utah hospitals
Source: ERJ Open Res, 2 (4) 00011-2016; 10.1183/23120541.00011-2016
Year: 2016
Urinary antigen testing for pneumococcal pneumonia: is there evidence to make its use uncommon in clinical practice?
Source: ERJ Open Res, 6 (1) 00223-2019; 10.1183/23120541.00223-2019
Year: 2020
Performance of the binax NOW
Streptococcus pneumoniae
urinary antigen assay among children with underlying pulmonary diseases in the absence of acute pneumococcal infection
Source: Eur Respir J 2004; 24: Suppl. 48, 391s
Year: 2004
Prognostic score systems and community-acquired bacteraemic pneumococcal pneumonia
Source: Eur Respir J 2006 Oct 01;28(4):816-823
Year: 2006
Sepsis severity predicts outcome in community-acquired pneumococcal pneumonia
Source: Eur Respir J 2007; 30: 517-524
Year: 2007
The risk factors of clinical practice for bacteremia in community- acquired pneumococcal pneumonia
Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment
Year: 2016
Lymphopenic community acquired pneumococcal pneumonia: Clinical characteristics and outcome
Source: Virtual Congress 2021 – Pneumonia
Year: 2021
Predictive and prognostic factors in patients with blood-culture-positive community-acquired pneumococcal pneumonia
Source: Eur Respir J 2016; 48: 797-807
Year: 2016
Streptococcus pneumoniae
resistance pattern and its clinical implications
Source: Annual Congress 2006 - PG1 - Respiratory infections: pneumonia/antibiotic resistance and clinical outcome of lower respiratory tract infections
Year: 2006
Changes in pathogens and pneumococcal serotypes causing community-acquired pneumonia in The Netherlands
Source: International Congress 2017 – Discussion of vaccines, biomarkers and risk factors analysis
Year: 2017
Risk factors for respiratory failure in pneumococcal pneumonia: the importance of pneumococcal serotypes
Source: Eur Respir J 2014; 43: 545-553
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept